Literature DB >> 27364511

FIB-4 Index is a Predictor of Background Liver Fibrosis and Long-Term Outcomes After Curative Resection of Hepatocellular Carcinoma.

Yukiyasu Okamura1, Ryo Ashida2, Yusuke Yamamoto2, Takaaki Ito2, Teiichi Sugiura2, Katsuhiko Uesaka2.   

Abstract

BACKGROUND: The FIB-4 index is a simple formula for predicting the degree of liver fibrosis. This study aimed to examine the relationship between the preoperative FIB-4 index and liver fibrosis in non-tumor regions of surgical specimens and to investigate whether the FIB-4 index is a useful predictor for long-term outcomes experienced by hepatocellular carcinoma (HCC) patients after curative resection.
METHODS: This study retrospectively analyzed 493 HCC patients treated with curative resection. The utility of the FIB-4 index as a predictor of advanced liver fibrosis (F3 or F4) was assessed. The cutoff value for the FIB-4 index was determined using a receiver operating characteristic curve analysis, and the impact of the FIB-4 index on overall and recurrence-free survival after surgery was evaluated.
RESULTS: Advanced liver fibrosis was found in 236 patients (47.9 %). The FIB-4 index was significantly higher for the patients with advanced liver fibrosis than for those without this condition (P < 0.001). An FIB-4 index of 2.87 was the optimal cutoff point for predicting advanced liver fibrosis. The multivariate analysis showed the FIB-4 index to be an independent prognostic factor for recurrence-free and overall survival after curative resection only for patients who underwent hepatectomy as initial treatment (hazard ratio, 1.47 and 1.59; 95 % confidence interval, 1.12-1.93 and 1.09-2.32; P = 0.006 and 0.016, respectively).
CONCLUSIONS: The study showed the FIB4-index to be a predictor of background liver fibrosis and long-term outcomes for HCC patients who underwent hepatectomy as their initial treatment.

Entities:  

Year:  2016        PMID: 27364511     DOI: 10.1245/s10434-016-5377-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  Comparison of FIB-4 Index and Child-Pugh Score in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma.

Authors:  Pan Zhou; Bo Chen; Xiong-Ying Miao; Jiang-Jiao Zhou; Li Xiong; Yu Wen; Heng Zou
Journal:  J Gastrointest Surg       Date:  2019-05-07       Impact factor: 3.452

2.  A Novel Score Predicts HBV-Related Hepatocellular Carcinoma Recurrence After Hepatectomy: a Retrospective Multicenter Study.

Authors:  Wei Qin; Li Wang; Beiyuan Hu; Shusheng Leng; Huan Tian; Huanxian Luo; Jia Yao; Xiaolong Chen; Chao Wu; Guihua Chen; Yang Yang
Journal:  J Gastrointest Surg       Date:  2018-11-16       Impact factor: 3.452

3.  Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agents.

Authors:  Chao-Min Huang; Tsung-Hui Hu; Kuo-Chin Chang; Po-Lin Tseng; Sheng-Nan Lu; Chien-Hung Chen; Jing-Houng Wang; Chuan-Mo Lee; Ming-Chao Tsai; Ming-Tsung Lin; Yi-Hao Yen; Chao-Hung Hung; Chung-Lung Cho; Cheng-Kun Wu
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

4.  Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes.

Authors:  Takuo Yoshimoto; Takayuki Furuki; Hiroyuki Kobori; Masaaki Miyakawa; Hitomi Imachi; Koji Murao; Akira Nishiyama
Journal:  J Investig Med       Date:  2017-06-08       Impact factor: 2.895

5.  ALBI/ST ratio versus FIB-4 and APRI as a predictor of posthepatectomy liver failure in hepatocellular carcinoma patients.

Authors:  Ze-Qun Zhang; Bo Yang; Heng Zou; Li Xiong; Xiong-Ying Miao; Yu Wen; Jiang-Jiao Zhou
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

6.  Impact of aspartate aminotransferase-to-platelet ratio index based score to assess posthepatectomy liver failure in patients with hepatocellular carcninoma.

Authors:  Kyohei Yugawa; Takashi Maeda; Shigeyuki Nagata; Jin Shiraishi; Akihiro Sakai; Shohei Yamaguchi; Kozo Konishi; Kenkichi Hashimoto
Journal:  World J Surg Oncol       Date:  2022-08-02       Impact factor: 3.253

7.  Preoperative aspartate aminotransferase to albumin ratio correlates with tumor characteristics and predicts outcome of hepatocellular carcinoma patients after curative hepatectomy: a multicenter study.

Authors:  Wei Peng; Junyi Shen; Junlong Dai; Shusheng Leng; Fei Xie; Yu Zhang; Shun Ran; Xin Sun; Tianfu Wen
Journal:  BMC Surg       Date:  2022-08-09       Impact factor: 2.030

8.  Fibrosis-4 Model Influences Results of Patients with Hepatocellular Carcinoma Undergoing Hepatectomy.

Authors:  Haiqing Wang; Aixiang Liu; Wentao Bo; Xielin Feng; Yong Hu; Lang Tian; Hui Zhang; Xiaoli Tang; Lixia Zhang
Journal:  Biomed Res Int       Date:  2018-07-02       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.